Diconift AQ 75mg Injection
Marketer
Curavax Pharmaceuticals Private Limited
Salt Composition
Diclofenac (75mg)
Overview Diconift AQ 75mg Injection
A 75mg injection of Diclofenac Sodium (e.g., Diconift AQ equivalent) provides analgesia. This injectable formulation treats pain, inflammation, joint stiffness, and articular pain associated with conditions such as rheumatoid and osteoarthritis, and acute musculoskeletal trauma. Parenteral administration is indicated when oral medication is infeasible. Administered intravenously or intramuscularly by a qualified medical professional only; self-injection is strictly prohibited. Patients with a history of cardiovascular events (e.g., heart disease, stroke) should inform their physician. Report any injection site reactions (pain, swelling, erythema) to your doctor immediately. Common adverse effects include nausea, emesis, cephalalgia, and local injection site reactions. For extended therapy, regular monitoring of renal and hepatic function, along with blood counts, may be necessary. Prolonged use carries risks of gastrointestinal bleeding and nephropathy.
Uses of Diconift AQ 75mg Injection
Analgesia
Major Benefits of Diconift AQ 75mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Diconift AQ 75mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Diconift AQ 75mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Diconift AQ 75mg Injection works:
Diconift AQ 75mg injection is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators, thus alleviating pain and reducing associated swelling and redness.
SAFETY ADVICE
AlcoholCAUTION
Use of Diconift AQ 75mg Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Diconift AQ 75mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Diconift AQ 75mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Diconift AQ 75mg Injection may induce adverse reactions that could impair driving capabilities.
KidneyCAUTION
For individuals with impaired kidney function, administering Diconift AQ 75mg Injection requires careful consideration. Dosage modification of Diconift AQ 75mg Injection might be necessary. A physician's consultation is advised.
LiverCAUTION
Patients with liver impairment should use Diconift AQ 75mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Diconift AQ 75mg Injection :
Omit a scheduled dose of Diconift AQ 75mg Injection? Seek your physician's advice.
Facts to Know About Diconift AQ 75mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylacetic Acid Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
3,018 People bought this recently